Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

Psyprax

First CVE: Feb 5, 2021Active for: 5 yearsTotal CVEs: 3

Psyprax's vulnerability footprint centers on its primary product and reflects a pattern of cryptographic and access-control weaknesses, including inadequate encryption strength, incorrect permission assignment, insecure default initialization, and insufficiently protected credentials. Treat this as a focused vendor profile; live severity, exploitation, and exposure counts are shown alongside this summary.

FAUCET AI Generated
3
Total CVEs
More Total CVEs than 72% of tracked vendors
3.0
Avg CVEs / Product / Year
More Avg CVEs / Product / Year than 91% of tracked vendors
7.0
Avg CVSS Score
Higher Avg CVSS Score than 50% of tracked vendors
0.0%
In CISA KEV
Bottom 1%

Trends Over Time

The number and severity of CVEs published that impact products developed by Psyprax over time

Volume of CVEsAvg CVSS Base Score
First CVE
Feb 5, 2021
5 years ago
Most Recent CVE
Feb 5, 2021
1,995 days ago

Products(1 total)

Top CVEs

Signals from CVEs in this vendor scope (3 CVEs).

3 CVEs · Highest risk first

CVEPublishedCVSSRiskKEVExploit
CVE-2020-10552HIGH
An issue was discovered in Psyprax before 3.2.2. The Firebird database is accessible with the default user sysdba and password masterke after installation. This allows any user to
Feb 5, 20218.125NONO
CVE-2020-10554HIGH
An issue was discovered in Psyprax beforee 3.2.2. Passwords used to encrypt the data are stored in the database in an obfuscated format, which can be easily reverted. For example,
Feb 5, 20217.524NONO
CVE-2020-10553MEDIUM
An issue was discovered in Psyprax before 3.2.2. The file %PROGRAMDATA%\Psyprax32\PPScreen.ini contains a hash for the lockscreen (aka screensaver) of the application. If that entr
Feb 5, 20215.516NONO
View all 3 CVEs →

CVE Severity & Scoring

Severity distribution of CVEs that affect this vendor's products3 CVEs
33%
67%
Severity distribution among all CVEs352,294 CVEs
45%
40%
11%
MediumHigh
Attack Vector
Local1 (33.3%)
Network2 (66.7%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low3 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None3 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low2 (66.7%)
High0 (0.0%)
None1 (33.3%)
Unknown0 (0.0%)

Exploit Exposure

Signals from CVEs in this vendor scope (3 CVEs).

CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%

Social Chatter

An overview of all social media posts that mention a CVE ID that affects a product developed by Psyprax.

Media Mentions

Media articles that mention a CVE ID that affects a product developed by Psyprax — matched by CVE ID, not by vendor name.

Top CNAs Publishing CVEs For Psyprax's Products

View all 1 CNAs →

Top CWEs